Lanxess stock trades at EUR 12.46, volume is 2.3 percent above average

Published on 10/08/2026 at 18:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Lanxess stock stood at EUR 12.46 on October 8, 2026, versus EUR 12.89. The next quarterly investor update is scheduled for November 5, 2026.

Key points in brief

Lanxess stock was trading at EUR 12.46 on October 8, 2026, down 3.34 percent versus the Xetra close of EUR 12.89.
Trading volume reached 484,683 shares, 2.26 percent above the average of 473,987 shares.
Market capitalization stood at EUR 1.1 billion, while the 52-week range was EUR 11.03 to EUR 22.02.
Lanxess will publish its third-quarter 2026 results on November 5, 2026, according to the company calendar.

Flatlay mit Aktienzertifikat, ISIN-Karte, Reagenzgläsern und Laborhandschuhen — Lanxess AG (DE0005470405) illustriert als edles Flatlay mit Aktienzertifikat, ISIN-Karte und typischen Laborutensilien der Chemiebranche, Illustration mit AI erstellt.

Lanxess stock was trading at EUR 12.46 at Lang & Schwarz on October 8, 2026 at 6:35 p.m. CEST. The price was down 3.34 percent versus the Xetra close of EUR 12.89 on October 7, while trading volume reached 484,683 shares.

Volume edges above its average

The share volume was 2.26 percent above the average of 473,987 shares, calculated from the same October 8, 2026 market figures. The comparison shows active turnover alongside the lower euro quotation, but it does not establish a reason for the move.

Lang & Schwarz quoted a bid of EUR 12.24 and an ask of EUR 12.68 at the same timestamp. The spread between the two quotes was EUR 0.44, giving investors a clear intraday indication of the trading range available at the venue.

Stock remains below yearly high

Lanxess traded 43.42 percent below its 52-week high of EUR 22.02 and EUR 1.43 above its 52-week low of EUR 11.03 on October 8, 2026. The distance to the high places the stock closer to the bottom of its annual range than to its upper boundary.

Market capitalization stood at EUR 1.1 billion on October 8, 2026. The price-to-earnings ratio was negative 1.6 on the same date, a valuation measure that reflects the reported loss position in the quoted market data.

Comparison with peers on October 8, 2026

Lanxess: minus 3.34 percent, P/E negative 1.6, market capitalization EUR 1.1 billion.

Bayer (Xetra, EUR): minus 3.14 percent, P/E negative 24.2, market capitalization EUR 41.8 billion.

BASF (Xetra, EUR): plus 1.15 percent, P/E 7.8, market capitalization EUR 44.6 billion.

Next results arrive in November

According to LANXESS, the company will publish its third-quarter 2026 results on November 5, 2026, with an investor-relations conference call at 1:00 p.m. CEST. That date gives the market a defined calendar point after the October 8 quotation.